Which has better earnings & valuation, SIA or EXE?

Extendicare has higher revenue and earnings than Sienna Senior Living. Extendicare is trading at a lower price-to-earnings ratio than Sienna Senior Living, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sienna Senior Living C$1.05B 2.25 C$33.51M C$0.48 46.13 Extendicare C$1.75B 1.90 C$65.46M C$1.36 25.86

Does the media refer more to SIA or EXE?

In the previous week, Sienna Senior Living had 1 more articles in the media than Extendicare. MarketBeat recorded 2 mentions for Sienna Senior Living and 1 mentions for Extendicare. Extendicare's average media sentiment score of 0.75 beat Sienna Senior Living's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sienna Senior Living 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Extendicare 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, DNTL or EXE?

Extendicare has higher revenue and earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio dentalcorp C$1.66B 1.32 -C$80.68M -C$0.14 N/A Extendicare C$1.75B 1.90 C$65.46M C$1.36 25.86

Do analysts recommend DR or EXE?

Extendicare has a consensus price target of C$32.56, indicating a potential downside of 7.38%. Given Extendicare's stronger consensus rating and higher probable upside, analysts plainly believe Extendicare is more favorable than Medical Facilities. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medical Facilities 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Extendicare 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25

Which has stronger earnings & valuation, DR or EXE?

Extendicare has higher revenue and earnings than Medical Facilities. Medical Facilities is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Medical Facilities C$260.72M 1.22 C$17.17M C$1.94 9.38 Extendicare C$1.75B 1.90 C$65.46M C$1.36 25.86

Does the media prefer DR or EXE?

In the previous week, Medical Facilities and Medical Facilities both had 1 articles in the media. Medical Facilities' average media sentiment score of 0.75 equaled Extendicare'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medical Facilities 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Extendicare 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer EXE or NLH?

Extendicare presently has a consensus price target of C$32.56, suggesting a potential downside of 7.38%. Given Extendicare's stronger consensus rating and higher probable upside, equities analysts clearly believe Extendicare is more favorable than Nova Leap Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Extendicare 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25 Nova Leap Health 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, EXE or NLH?

Extendicare has higher revenue and earnings than Nova Leap Health. Extendicare is trading at a lower price-to-earnings ratio than Nova Leap Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Extendicare C$1.75B 1.90 C$65.46M C$1.36 25.86 Nova Leap Health C$32.23M 1.08 -C$300.30K C$0.00 133.33

Extendicare (EXE) Competitors

C$35.15 +1.02 (+2.99%)

As of 02:34 PM Eastern

Compare

EXE vs. SIA, DNTL, WELL, DR, and NLH

Should you buy Extendicare stock or one of its competitors? MarketBeat compares Extendicare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Extendicare include Sienna Senior Living (SIA), dentalcorp (DNTL), WELL Health Technologies (WELL), Medical Facilities (DR), and Nova Leap Health (NLH). These companies are all part of the "medical care facilities" industry.

How does Extendicare compare to Sienna Senior Living?

Sienna Senior Living (TSE:SIA) and Extendicare (TSE:EXE) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Extendicare has higher revenue and earnings than Sienna Senior Living. Extendicare is trading at a lower price-to-earnings ratio than Sienna Senior Living, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sienna Senior Living	C$1.05B	2.25	C$33.51M	C$0.48	46.13
Extendicare	C$1.75B	1.90	C$65.46M	C$1.36	25.86

Sienna Senior Living has a beta of 1.098577, indicating that its share price is 10% more volatile than the broader market. Comparatively, Extendicare has a beta of 1.57403, indicating that its share price is 57% more volatile than the broader market.

Sienna Senior Living pays an annual dividend of C$0.94 per share and has a dividend yield of 4.2%. Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.4%. Sienna Senior Living pays out 195.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Extendicare pays out 37.2% of its earnings in the form of a dividend.

In the previous week, Sienna Senior Living had 1 more articles in the media than Extendicare. MarketBeat recorded 2 mentions for Sienna Senior Living and 1 mentions for Extendicare. Extendicare's average media sentiment score of 0.75 beat Sienna Senior Living's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sienna Senior Living	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Extendicare	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Extendicare has a net margin of 6.99% compared to Sienna Senior Living's net margin of 4.34%. Extendicare's return on equity of 45.35% beat Sienna Senior Living's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sienna Senior Living	4.34%	6.44%	3.58%
Extendicare	6.99%	45.35%	7.16%

Sienna Senior Living currently has a consensus target price of C$26.09, suggesting a potential upside of 17.85%. Extendicare has a consensus target price of C$32.56, suggesting a potential downside of 7.38%. Given Sienna Senior Living's higher probable upside, equities analysts clearly believe Sienna Senior Living is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sienna Senior Living	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	1 Strong Buy rating(s)	3.00
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

28.0% of Sienna Senior Living shares are owned by institutional investors. Comparatively, 24.2% of Extendicare shares are owned by institutional investors. 0.1% of Sienna Senior Living shares are owned by insiders. Comparatively, 13.9% of Extendicare shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Extendicare beats Sienna Senior Living on 12 of the 19 factors compared between the two stocks.

How does Extendicare compare to dentalcorp?

dentalcorp (TSE:DNTL) and Extendicare (TSE:EXE) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

Extendicare has higher revenue and earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
dentalcorp	C$1.66B	1.32	-C$80.68M	-C$0.14	N/A
Extendicare	C$1.75B	1.90	C$65.46M	C$1.36	25.86

dentalcorp pays an annual dividend of C$0.08 per share and has a dividend yield of 0.7%. Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.4%. dentalcorp pays out -53.6% of its earnings in the form of a dividend. Extendicare pays out 37.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, Extendicare had 1 more articles in the media than dentalcorp. MarketBeat recorded 1 mentions for Extendicare and 0 mentions for dentalcorp. Extendicare's average media sentiment score of 0.75 beat dentalcorp's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.

Company	Overall Sentiment
dentalcorp	Neutral
Extendicare	Positive

17.9% of dentalcorp shares are held by institutional investors. Comparatively, 24.2% of Extendicare shares are held by institutional investors. 0.2% of dentalcorp shares are held by insiders. Comparatively, 13.9% of Extendicare shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Extendicare has a net margin of 6.99% compared to dentalcorp's net margin of -1.64%. Extendicare's return on equity of 45.35% beat dentalcorp's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
dentalcorp	-1.64%	-1.54%	0.77%
Extendicare	6.99%	45.35%	7.16%

dentalcorp currently has a consensus target price of C$11.00, suggesting a potential upside of 0.00%. Extendicare has a consensus target price of C$32.56, suggesting a potential downside of 7.38%. Given dentalcorp's higher possible upside, equities analysts plainly believe dentalcorp is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
dentalcorp	1 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.80
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

dentalcorp has a beta of 1.469634, indicating that its share price is 47% more volatile than the broader market. Comparatively, Extendicare has a beta of 1.57403, indicating that its share price is 57% more volatile than the broader market.

Summary

Extendicare beats dentalcorp on 17 of the 19 factors compared between the two stocks.

How does Extendicare compare to WELL Health Technologies?

WELL Health Technologies (TSE:WELL) and Extendicare (TSE:EXE) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations.

WELL Health Technologies has higher earnings, but lower revenue than Extendicare. Extendicare is trading at a lower price-to-earnings ratio than WELL Health Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
WELL Health Technologies	C$1.47B	0.72	C$73.76M	C$0.11	38.00
Extendicare	C$1.75B	1.90	C$65.46M	C$1.36	25.86

5.1% of WELL Health Technologies shares are held by institutional investors. Comparatively, 24.2% of Extendicare shares are held by institutional investors. 6.8% of WELL Health Technologies shares are held by company insiders. Comparatively, 13.9% of Extendicare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Extendicare had 1 more articles in the media than WELL Health Technologies. MarketBeat recorded 1 mentions for Extendicare and 0 mentions for WELL Health Technologies. Extendicare's average media sentiment score of 0.75 beat WELL Health Technologies' score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.

Company	Overall Sentiment
WELL Health Technologies	Neutral
Extendicare	Positive

WELL Health Technologies presently has a consensus price target of C$6.92, indicating a potential upside of 65.47%. Extendicare has a consensus price target of C$32.56, indicating a potential downside of 7.38%. Given WELL Health Technologies' higher probable upside, research analysts clearly believe WELL Health Technologies is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
WELL Health Technologies	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

Extendicare has a net margin of 6.99% compared to WELL Health Technologies' net margin of 1.82%. Extendicare's return on equity of 45.35% beat WELL Health Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
WELL Health Technologies	1.82%	3.15%	2.07%
Extendicare	6.99%	45.35%	7.16%

WELL Health Technologies has a beta of 0.865672, meaning that its stock price is 13% less volatile than the broader market. Comparatively, Extendicare has a beta of 1.57403, meaning that its stock price is 57% more volatile than the broader market.

Summary

Extendicare beats WELL Health Technologies on 14 of the 17 factors compared between the two stocks.

How does Extendicare compare to Medical Facilities?

Medical Facilities (TSE:DR) and Extendicare (TSE:EXE) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings.

Medical Facilities has a net margin of 8.51% compared to Extendicare's net margin of 6.99%. Extendicare's return on equity of 45.35% beat Medical Facilities' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Medical Facilities	8.51%	31.06%	13.60%
Extendicare	6.99%	45.35%	7.16%

Medical Facilities has a beta of 0.502064, suggesting that its stock price is 50% less volatile than the broader market. Comparatively, Extendicare has a beta of 1.57403, suggesting that its stock price is 57% more volatile than the broader market.

Medical Facilities pays an annual dividend of C$0.26 per share and has a dividend yield of 1.4%. Extendicare pays an annual dividend of C$0.51 per share and has a dividend yield of 1.4%. Medical Facilities pays out 13.4% of its earnings in the form of a dividend. Extendicare pays out 37.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

15.7% of Medical Facilities shares are owned by institutional investors. Comparatively, 24.2% of Extendicare shares are owned by institutional investors. 0.4% of Medical Facilities shares are owned by insiders. Comparatively, 13.9% of Extendicare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Extendicare has higher revenue and earnings than Medical Facilities. Medical Facilities is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Medical Facilities	C$260.72M	1.22	C$17.17M	C$1.94	9.38
Extendicare	C$1.75B	1.90	C$65.46M	C$1.36	25.86

Extendicare has a consensus price target of C$32.56, indicating a potential downside of 7.38%. Given Extendicare's stronger consensus rating and higher probable upside, analysts plainly believe Extendicare is more favorable than Medical Facilities.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Medical Facilities	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25

In the previous week, Medical Facilities and Medical Facilities both had 1 articles in the media. Medical Facilities' average media sentiment score of 0.75 equaled Extendicare'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Medical Facilities	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Extendicare	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Extendicare beats Medical Facilities on 13 of the 17 factors compared between the two stocks.

How does Extendicare compare to Nova Leap Health?

Extendicare (TSE:EXE) and Nova Leap Health (CVE:NLH) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability, media sentiment and analyst recommendations.

24.2% of Extendicare shares are held by institutional investors. Comparatively, 0.0% of Nova Leap Health shares are held by institutional investors. 13.9% of Extendicare shares are held by insiders. Comparatively, 40.8% of Nova Leap Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Extendicare presently has a consensus price target of C$32.56, suggesting a potential downside of 7.38%. Given Extendicare's stronger consensus rating and higher probable upside, equities analysts clearly believe Extendicare is more favorable than Nova Leap Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Extendicare	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	3.25
Nova Leap Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Extendicare has a beta of 1.57403, indicating that its stock price is 57% more volatile than the broader market. Comparatively, Nova Leap Health has a beta of 1.961788, indicating that its stock price is 96% more volatile than the broader market.

In the previous week, Extendicare had 1 more articles in the media than Nova Leap Health. MarketBeat recorded 1 mentions for Extendicare and 0 mentions for Nova Leap Health. Extendicare's average media sentiment score of 0.75 beat Nova Leap Health's score of 0.00 indicating that Extendicare is being referred to more favorably in the media.

Company	Overall Sentiment
Extendicare	Positive
Nova Leap Health	Neutral

Extendicare has higher revenue and earnings than Nova Leap Health. Extendicare is trading at a lower price-to-earnings ratio than Nova Leap Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Extendicare	C$1.75B	1.90	C$65.46M	C$1.36	25.86
Nova Leap Health	C$32.23M	1.08	-C$300.30K	C$0.00	133.33

Extendicare has a net margin of 6.99% compared to Nova Leap Health's net margin of 0.64%. Extendicare's return on equity of 45.35% beat Nova Leap Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Extendicare	6.99%	45.35%	7.16%
Nova Leap Health	0.64%	1.10%	2.77%

Summary

Extendicare beats Nova Leap Health on 14 of the 17 factors compared between the two stocks.

Get Extendicare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding EXE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

EXE vs. The Competition

Export

Metric	Extendicare	Medical Care Facilities Industry	Medical Sector	TSE Exchange
Market Cap	C$3.33B	C$1.73B	C$6.54B	C$12.14B
Dividend Yield	1.50%	3.70%	2.69%	6.19%
P/E Ratio	25.86	13.05	25.16	35.23
Price / Sales	1.90	18.34	554.14	10.14
Price / Cash	3.20	7.90	44.82	82.29
Price / Book	8.53	1.81	10.80	4.37
Net Income	C$65.46M	C$63.03M	C$3.56B	C$299.09M
7 Day Performance	6.55%	1.47%	1.50%	-2.19%
1 Month Performance	3.63%	4.18%	0.93%	-2.40%
1 Year Performance	151.07%	13.63%	30.55%	37.43%

Extendicare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
EXE Extendicare	2.0021 of 5 stars	C$35.15 +3.0%	C$32.56 -7.4%	+142.4%	C$3.33B	C$1.75B	25.86	23,000
SIA Sienna Senior Living	2.63 of 5 stars	C$21.71 +1.2%	C$26.09 +20.2%	+18.4%	C$2.30B	C$1.05B	45.23	12,000	News Coverage Dividend Announcement
DNTL dentalcorp	N/A	C$11.00 +0.1%	C$11.00	+35.8%	C$2.19B	C$1.66B	N/A	9,950
WELL WELL Health Technologies	1.7994 of 5 stars	C$4.41 -1.6%	C$6.92 +56.8%	+9.0%	C$1.13B	C$1.47B	40.09	510
DR Medical Facilities	N/A	C$17.70 -1.0%	N/A	+18.0%	C$310.64M	C$260.72M	9.12	1,833	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (TSE:EXE) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Extendicare (EXE) Competitors

EXE vs. SIA, DNTL, WELL, DR, and NLH

How does Extendicare compare to Sienna Senior Living?

Summary

How does Extendicare compare to dentalcorp?

Summary

How does Extendicare compare to WELL Health Technologies?

Summary

How does Extendicare compare to Medical Facilities?

Summary

How does Extendicare compare to Nova Leap Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EXE vs. The Competition

Extendicare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Extendicare (EXE) Competitors

EXE vs. SIA, DNTL, WELL, DR, and NLH

How does Extendicare compare to Sienna Senior Living?

Which has better earnings & valuation, SIA or EXE?

Which has more risk and volatility, SIA or EXE?

Is SIA or EXE a better dividend stock?

Does the media refer more to SIA or EXE?

Is SIA or EXE more profitable?

Do analysts recommend SIA or EXE?

Do insiders and institutionals believe in SIA or EXE?

Summary

How does Extendicare compare to dentalcorp?

Which has preferable earnings & valuation, DNTL or EXE?

Is DNTL or EXE a better dividend stock?

Does the media refer more to DNTL or EXE?

Do institutionals and insiders believe in DNTL or EXE?

Is DNTL or EXE more profitable?

Do analysts rate DNTL or EXE?

Which has more risk & volatility, DNTL or EXE?

Summary

How does Extendicare compare to WELL Health Technologies?

Which has higher earnings and valuation, WELL or EXE?

Do institutionals and insiders believe in WELL or EXE?

Does the media refer more to WELL or EXE?

Do analysts prefer WELL or EXE?

Is WELL or EXE more profitable?

Which has more volatility and risk, WELL or EXE?

Summary

How does Extendicare compare to Medical Facilities?

Is DR or EXE more profitable?

Which has more risk & volatility, DR or EXE?

Is DR or EXE a better dividend stock?

Do institutionals and insiders hold more shares of DR or EXE?

Which has stronger earnings & valuation, DR or EXE?

Do analysts recommend DR or EXE?

Does the media prefer DR or EXE?

Summary

How does Extendicare compare to Nova Leap Health?

Do insiders & institutionals have more ownership in EXE or NLH?

Do analysts prefer EXE or NLH?

Which has more volatility & risk, EXE or NLH?

Does the media prefer EXE or NLH?

Which has stronger earnings and valuation, EXE or NLH?

Is EXE or NLH more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

EXE vs. The Competition

Extendicare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools